Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Ablative Solutions, Daxor, Purplesun, Oxford Immunotec, Tandem Diabetes Care.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: BBS-Bioactive Bone Substitutes, Nantomics, Nanthealth.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ATCG, Delmar, Immutep, Lidds, Matinas, Molecular Templates, Palatin, Reneuron, Restorbio, Takeda, Terns, Zelira.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Aravive, Axim, Azurrx, Bellerophon, Bioxcel, BMS, Eisai, Five Prime, Foamix, Mirati, Moleculin, Mustang, Ra, Recardio, Reneo, Sensorion.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acucela, Astellas, Celltrion Healthcare, Kubota, Noxopharm, Pfizer, Seattle Genetics, Takeda, TLC Co.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atreca, Celltrion, Cytodyn, Genetx, Janssen, Noxopharm, Regulus, Sol-Gel, Takeda, Verona.